Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash to Debt 0.40
CMN's Cash to Debt is ranked higher than
57% of the 287 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.15 vs. CMN: 0.40 )
CMN' s 10-Year Cash to Debt Range
Min: 0.08   Max: No Debt
Current: 0.4

Equity to Asset 0.68
CMN's Equity to Asset is ranked higher than
77% of the 275 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.60 vs. CMN: 0.68 )
CMN' s 10-Year Equity to Asset Range
Min: 0.37   Max: 0.75
Current: 0.68

0.37
0.75
Interest Coverage 29.80
CMN's Interest Coverage is ranked higher than
69% of the 182 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 32.42 vs. CMN: 29.80 )
CMN' s 10-Year Interest Coverage Range
Min: 1.4   Max: 9999.99
Current: 29.8

1.4
9999.99
F-Score: 6
Z-Score: 8.54
M-Score: -2.49
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 14.51
CMN's Operating margin (%) is ranked higher than
85% of the 286 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.64 vs. CMN: 14.51 )
CMN' s 10-Year Operating margin (%) Range
Min: 2.05   Max: 14.87
Current: 14.51

2.05
14.87
Net-margin (%) 8.85
CMN's Net-margin (%) is ranked higher than
81% of the 286 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.97 vs. CMN: 8.85 )
CMN' s 10-Year Net-margin (%) Range
Min: -2.35   Max: 12.33
Current: 8.85

-2.35
12.33
ROE (%) 12.63
CMN's ROE (%) is ranked higher than
84% of the 276 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.15 vs. CMN: 12.63 )
CMN' s 10-Year ROE (%) Range
Min: 5.06   Max: 22.36
Current: 12.63

5.06
22.36
ROA (%) 8.65
CMN's ROA (%) is ranked higher than
85% of the 288 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.87 vs. CMN: 8.65 )
CMN' s 10-Year ROA (%) Range
Min: 2.4   Max: 15.4
Current: 8.65

2.4
15.4
ROC (Joel Greenblatt) (%) 58.59
CMN's ROC (Joel Greenblatt) (%) is ranked higher than
92% of the 287 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 20.54 vs. CMN: 58.59 )
CMN' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 18.58   Max: 61.08
Current: 58.59

18.58
61.08
Revenue Growth (%) 12.60
CMN's Revenue Growth (%) is ranked higher than
88% of the 261 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.50 vs. CMN: 12.60 )
CMN' s 10-Year Revenue Growth (%) Range
Min: -6.6   Max: 28.8
Current: 12.6

-6.6
28.8
EBITDA Growth (%) 24.50
CMN's EBITDA Growth (%) is ranked higher than
89% of the 219 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.30 vs. CMN: 24.50 )
CMN' s 10-Year EBITDA Growth (%) Range
Min: 1.2   Max: 43.3
Current: 24.5

1.2
43.3
EPS Growth (%) 25.20
CMN's EPS Growth (%) is ranked higher than
87% of the 218 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.90 vs. CMN: 25.20 )
CMN' s 10-Year EPS Growth (%) Range
Min: -17.7   Max: 54.2
Current: 25.2

-17.7
54.2
» CMN's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q4 2013

CMN Guru Trades in Q4 2013

Paul Tudor Jones 10,600 sh (New)
Steven Cohen 11,157 sh (New)
Jim Simons 43,350 sh (+295.89%)
Mario Gabelli 424,009 sh (-1.02%)
Chuck Royce 90,338 sh (-11.81%)
» More
Q1 2014

CMN Guru Trades in Q1 2014

RS Investment Management 4,606 sh (New)
Jim Simons 67,550 sh (+55.82%)
Paul Tudor Jones Sold Out
Steven Cohen Sold Out
Mario Gabelli 415,509 sh (-2%)
Chuck Royce 72,438 sh (-19.81%)
» More
Q2 2014

CMN Guru Trades in Q2 2014

Joel Greenblatt 21,913 sh (New)
RS Investment Management 6,306 sh (+36.91%)
Mario Gabelli 395,973 sh (-4.7%)
Chuck Royce 58,438 sh (-19.33%)
Jim Simons 45,450 sh (-32.72%)
» More
Q3 2014

CMN Guru Trades in Q3 2014

RS Investment Management Sold Out
Mario Gabelli 389,748 sh (-1.57%)
Joel Greenblatt 17,444 sh (-20.39%)
Chuck Royce 46,438 sh (-20.53%)
Jim Simons 33,650 sh (-25.96%)
» More
» Details

Insider Trades

Latest Guru Trades with CMN

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Joel Greenblatt 2014-09-30 Reduce -20.39%$33.81 - $37.04 $ 43.5423%17444
Joel Greenblatt 2014-06-30 New Buy0.01%$30.52 - $36.79 $ 43.5428%21913
Joel Greenblatt 2013-06-30 Sold Out 0.02%$19.533 - $23.5 $ 43.54101%0
Mario Gabelli 2013-06-30 Reduce -33.57%0.02%$19.533 - $23.5 $ 43.54101%281891
Joel Greenblatt 2013-03-31 Reduce -26.39%0.01%$12.85 - $14.59 $ 43.54214%11679
Joel Greenblatt 2012-12-31 New Buy0.03%$10.93 - $13.33 $ 43.54261%15865
Mario Gabelli 2012-06-30 Add 25.22%0.01%$9.29 - $12.08 $ 43.54319%274292
Mario Gabelli 2012-03-31 Add 63.41%0.02%$8.17 - $11.35 $ 43.54390%219042
John Keeley 2012-03-31 Sold Out 0.01%$8.17 - $11.35 $ 43.54390%0
Mario Gabelli 2011-09-30 Add 23.19%$5.89 - $8.38 $ 43.54510%85000
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 42.00
CMN's P/E(ttm) is ranked higher than
75% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 42.50 vs. CMN: 42.00 )
CMN' s 10-Year P/E(ttm) Range
Min: 9.24   Max: 41.99
Current: 42

9.24
41.99
P/B 4.94
CMN's P/B is ranked higher than
63% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.51 vs. CMN: 4.94 )
CMN' s 10-Year P/B Range
Min: 0.77   Max: 4.94
Current: 4.94

0.77
4.94
P/S 3.64
CMN's P/S is ranked higher than
67% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.92 vs. CMN: 3.64 )
CMN' s 10-Year P/S Range
Min: 0.51   Max: 3.64
Current: 3.64

0.51
3.64
PFCF 35.11
CMN's PFCF is ranked higher than
84% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 719.57 vs. CMN: 35.11 )
CMN' s 10-Year PFCF Range
Min: 7.16   Max: 809.8
Current: 35.11

7.16
809.8
EV-to-EBIT 26.13
CMN's EV-to-EBIT is ranked higher than
76% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 29.27 vs. CMN: 26.13 )
CMN' s 10-Year EV-to-EBIT Range
Min: 7.7   Max: 34.9
Current: 26.13

7.7
34.9
PEG 2.07
CMN's PEG is ranked higher than
93% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9999.00 vs. CMN: 2.07 )
CMN' s 10-Year PEG Range
Min: 0.53   Max: 5.08
Current: 2.07

0.53
5.08
Shiller P/E 58.79
CMN's Shiller P/E is ranked higher than
79% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 398.57 vs. CMN: 58.79 )
CMN' s 10-Year Shiller P/E Range
Min: 8.99   Max: 59.24
Current: 58.79

8.99
59.24
Current Ratio 2.46
CMN's Current Ratio is ranked higher than
66% of the 275 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.72 vs. CMN: 2.46 )
CMN' s 10-Year Current Ratio Range
Min: 2.11   Max: 4.68
Current: 2.46

2.11
4.68
Quick Ratio 1.57
CMN's Quick Ratio is ranked higher than
64% of the 275 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.85 vs. CMN: 1.57 )
CMN' s 10-Year Quick Ratio Range
Min: 1.36   Max: 2.41
Current: 1.57

1.36
2.41

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.20
CMN's Dividend Yield is ranked lower than
91% of the 148 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.34 vs. CMN: 0.20 )
CMN' s 10-Year Dividend Yield Range
Min: 0.2   Max: 0.7
Current: 0.2

0.2
0.7
Dividend Payout 0.09
CMN's Dividend Payout is ranked higher than
97% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9999.00 vs. CMN: 0.09 )
CMN' s 10-Year Dividend Payout Range
Min: 0.08   Max: 0.1
Current: 0.09

0.08
0.1
Dividend growth (3y) 19.30
CMN's Dividend growth (3y) is ranked higher than
87% of the 109 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 11.40 vs. CMN: 19.30 )
CMN' s 10-Year Dividend growth (3y) Range
Min: 0   Max: 19.3
Current: 19.3

0
19.3
Yield on cost (5-Year) 0.48
CMN's Yield on cost (5-Year) is ranked lower than
80% of the 151 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.63 vs. CMN: 0.48 )
CMN' s 10-Year Yield on cost (5-Year) Range
Min: 0.48   Max: 1.69
Current: 0.48

0.48
1.69
Share Buyback Rate -2.10
CMN's Share Buyback Rate is ranked higher than
76% of the 239 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: -2.30 vs. CMN: -2.10 )
CMN' s 10-Year Share Buyback Rate Range
Min: -0.5   Max: -13.8
Current: -2.1

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 35.68
CMN's Price/Tangible Book is ranked higher than
58% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 7.41 vs. CMN: 35.68 )
CMN' s 10-Year Price/Tangible Book Range
Min: 1.94   Max: 33.49
Current: 35.68

1.94
33.49
Price/DCF (Projected) 2.18
CMN's Price/DCF (Projected) is ranked higher than
81% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.87 vs. CMN: 2.18 )
CMN' s 10-Year Price/DCF (Projected) Range
Min: 0.58   Max: 5.04
Current: 2.18

0.58
5.04
Price/Median PS Value 2.62
CMN's Price/Median PS Value is ranked higher than
52% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.20 vs. CMN: 2.62 )
CMN' s 10-Year Price/Median PS Value Range
Min: 0.31   Max: 2.07
Current: 2.62

0.31
2.07
Price/Peter Lynch Fair Value 2.24
CMN's Price/Peter Lynch Fair Value is ranked higher than
92% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9999.00 vs. CMN: 2.24 )
CMN' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.47   Max: 4.05
Current: 2.24

0.47
4.05
Price/Graham Number 8.12
CMN's Price/Graham Number is ranked higher than
71% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 6.72 vs. CMN: 8.12 )
CMN' s 10-Year Price/Graham Number Range
Min: 1.08   Max: 6.42
Current: 8.12

1.08
6.42
Earnings Yield (Greenblatt) 3.80
CMN's Earnings Yield (Greenblatt) is ranked higher than
75% of the 284 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.00 vs. CMN: 3.80 )
CMN' s 10-Year Earnings Yield (Greenblatt) Range
Min: 2.9   Max: 13.1
Current: 3.8

2.9
13.1
Forward Rate of Return (Yacktman) 20.85
CMN's Forward Rate of Return (Yacktman) is ranked higher than
96% of the 247 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.17 vs. CMN: 20.85 )
CMN' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 10.5   Max: 38
Current: 20.85

10.5
38

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare:WST, BAX, COV, TMO, COO » details
Traded in other countries:CI2.Germany
Cantel Medical Corp was incorporated in Delaware. The Company is a provider of infection prevention and control products in the healthcare market. Its operating segments include: Endoscopy, Water Purification and Filtration, Healthcare Disposables, Dialysis, and Specialty Packaging. Endoscopy segment offers medical device reprocessing systems, disinfectants, detergents and other supplies used to high-level disinfect flexible endoscopes. This segment also offers disposable infection control products intended to eliminate the challenges associated with proper cleaning and high-level disinfection of numerous reusable components used in gastrointestinal (GI) endoscopy procedures. Water Purification and Filtration segment offers water purification equipment and services, filtration and separation products, and disinfectants for the medical, pharmaceutical, biotech, beverage and commercial industrial markets. The healthcare Disposables segment offers single-use, infection prevention and control healthcare products used principally in the dental market including face masks, sterilization pouches, towels and bibs, tray covers, saliva ejectors, germicidal wipes, plastic cups and disinfectants. This segment also manufactures and provides biological and chemical indicators for sterility assurance monitoring services in the acute-care, alternate-care and dental markets. Dialysis segment offers medical device reprocessing systems, sterilants/disinfectants, dialysate concentrates and other supplies for renal dialysis. Specialty Packaging segment offers specialty packaging and thermal control products, as well as related compliance training, for the transport of infectious and biological specimens and thermally sensitive pharmaceutical, medical and other products. The Company sells and services its endoscope reprocessing equipment, high-level disinfectants, cleaners and consumables through its own United States field sales and service organization. Outside of the United States, it sells through independent distribution partners in Europe, Canada, Asia, Australia and Latin America as well as its own sales and service organizations in the Netherlands and Singapore. Its Competitors include Kimberly-Clark, 3M, Steris, Danaher/Sybron, Dentsply/Sultan Healthcare, Amcor. The Company's products are subject to regulation by the FDA, which regulates the testing, manufacturing, packaging, distribution and marketing of its medical devices and water purification devices in the United States.
» More Articles for CMN

Headlines

Articles On GuruFocus.com
Small items not cut Mar 03 2013 
Cantel Medical Corp. (CMN) Sr. V.P., CFO and Treasurer Craig A Sheldon sells 2,607 Shares Mar 15 2011 
Cantel Medical Corp. Reports Operating Results (10-Q) Mar 11 2011 
Cantel Medical Corp. Reports Operating Results (10-Q) Dec 10 2010 
Cantel Medical Corp. Reports Operating Results (10-K) Oct 14 2010 
Cantel Medical Corp. Reports Operating Results (10-Q) Jun 09 2010 
Cantel Medical Corp. (CMN) President and CEO Andrew A Krakauer sells 11,505 Shares Apr 09 2010 
Cantel Medical Corp. (CMN) Chairman, 10% Owner Charles M Diker buys 5,000 Shares Oct 26 2009 
Cantel Medical Corp. Reports Operating Results (10-Q) Jun 08 2009 
Cantel Medical Corp. Reports Operating Results (10-Q) Mar 12 2009 

More From Other Websites
Cantel Medical To Present At The 26th Annual Piper Jaffray Healthcare Conference Nov 20 2014
Cantel Medical To Present At The 26th Annual Piper Jaffray Healthcare Conference Nov 20 2014
CANTEL MEDICAL CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Nov 19 2014
CANTEL MEDICAL CORP Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits Nov 18 2014
Cantel Medical Corp. Names Jorgen Hansen as President and COO and Announces Other Corporate... Nov 17 2014
Cantel Medical Corp. Names Jorgen Hansen as President and COO and Announces Other Corporate... Nov 17 2014
CANTEL MEDICAL CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Nov 12 2014
Cantel Medical To Present At The Stifel 2014 Healthcare Conference Nov 10 2014
Cantel Medical To Present At The Stifel 2014 Healthcare Conference Nov 10 2014
Cantel Medical Board Of Directors Authorizes Increase In Semiannual Dividend Nov 07 2014
Cantel Medical Board Of Directors Authorizes Increase In Semiannual Dividend Nov 07 2014
Cantel Medical Acquires International Medical Service S.r.l. Nov 04 2014
Cantel Medical Acquires International Medical Service S.r.l. Nov 04 2014
New York Surgical Mask Manufacturer Responds to PPE Recommendations, Healthcare Worker Concerns Oct 28 2014
Cantel Medical Named to the Forbes 2014 List of the "100 Best Small Companies in America" Oct 23 2014
Cantel Medical Named to the Forbes 2014 List of the "100 Best Small Companies in America" Oct 23 2014
CANTEL MEDICAL CORP Financials Oct 04 2014
10-K for Cantel Medical Corp. Oct 01 2014
Cantel Medical Corp. Q4 Conference Call Highlights Sep 29 2014
CANTEL MEDICAL CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Sep 29 2014

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK